Creative Medical Technology Holdings, Inc. Fair Value of Assets Acquired
Creative Medical Technology Holdings, Inc. (CELZ) reported Fair Value of Assets Acquired of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-01.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueOfAssetsAcquired · last filed 2019-04-01
- Creative Medical Technology Holdings, Inc. fair value of assets acquired for the quarter ending 2018-12-31 was $0.00.
- Creative Medical Technology Holdings, Inc. fair value of assets acquired for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- Creative Medical Technology Holdings, Inc. fair value of assets acquired for the quarter ending 2016-12-31 was $1.00K.
- Creative Medical Technology Holdings, Inc. fair value of assets acquired for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- Creative Medical Technology Holdings, Inc. fair value of assets acquired for fiscal 2017 was $100.00K, a 9900.00% increase from fiscal 2016.
- Creative Medical Technology Holdings, Inc. fair value of assets acquired for fiscal 2016 was $1.00K.
| Period end | Fair Value of Assets Acquired 3 month | Fair Value of Assets Acquired 9 month | Fair Value of Assets Acquired 12 month |
|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $0.00 10-K · filed 2019-04-01 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-14 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $100.00K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $100.00K 10-Q · filed 2018-11-14 | ||
| 2016-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $1.00K 10-K · filed 2018-03-29 | |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |